Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin

12. november 2026 oppdatert av: BrocShot Inc

This is a randomized, double-blind, placebo-controlled, fully decentralized (remote) clinical trial evaluating the effects of Broc Shot Capsules on skin appearance and comfort in adults with reactive, blemish-prone, or hormonally affected skin. Fifty participants aged 18-65 years will be randomly assigned in a 1:1 ratio to receive either Broc Shot Capsules (active) or matched placebo capsules for 8 weeks.

Participants will take 2 capsules once daily and complete self-reported questionnaires and standardized self-captured skin photographs at Baseline, Week 4, and Week 8 via a secure online study platform. Expert dermatologist grading of photographs will be conducted remotely at each timepoint. The study is designed to substantiate consumer product claims related to visible skin improvement and participant-reported skin comfort, and is not intended to evaluate treatment of any clinical dermatological disease.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Nevada
      • Las Vegas, Nevada, Forente stater, 89101
        • Citruslabs

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18 to 65 years (inclusive) at the time of consent.
  • Self-reported skin concerns matching at least one of the following descriptions: I have red, itchy skin patches
  • I have dry, flaky/scaley skin patches
  • my skin has blemishes such as pimples, discoloured papules (small, tender bumps that are pink/red/purple/or darker than your natural skin tone) or pustules (a distinct white or yellow pus-filled center surrounded by a red base).
  • Generally healthy adults who are willing and able to follow the study protocol for the full 8-week duration, including taking 2 capsules of the study product once daily for 8 consecutive weeks without skipping days, answering questionnaires at Baseline, Week 4, and Week 8, and following the photograph submission protocol at Baseline, Week 4, and Week 8.
  • Willing to avoid initiating any new topical or oral skincare products, prescription medications targeting skin, or other dietary supplements specifically marketed for skin benefit during the study period.
  • Participants currently using such products who have been using them consistently for at least 3 months prior to enrollment and are willing to continue unchanged throughout the study are eligible.
  • Willing to maintain their current diet, lifestyle, sleep pattern, sun exposure habits, and skincare routine for the duration of the trial.
  • Resides within the United States.
  • Access to a smartphone or computer with internet connection and the ability to use the Citruslabs digital study platform.

Exclusion Criteria:

  • Known allergy, hypersensitivity, or intolerance to broccoli, horseradish, other cruciferous vegetables (Brassicaceae family), or any component of the study product or placebo capsule.
  • Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Currently taking prescription anticoagulant medications (e.g., warfarin, apixaban, rivaroxaban) due to the potential for product ingredients to interact with anticoagulant activity.
  • History of a severe or unstable medical condition that, in the opinion of the study team, would prevent safe participation or adherence to the protocol, including active cancer treatment.
  • Currently using any oral, topical, or biologic prescription medication specifically indicated for a diagnosed dermatological condition, unless the regimen has been stable for at least 3 months and no changes are planned during the study period.
  • Planned dermatological procedures during the study period (e.g., chemical peels, laser treatments, microneedling, injectable cosmetic procedures) that could confound skin appearance assessments.
  • Currently enrolled in another clinical or consumer research study, or plans to enroll in any such study during the 8-week study period.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Placebo komparator: Placebo komparator

Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids.

Eksperimentell: BrocShot Collagen

Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Clinician-Assessed Change in Overall Skin Appearance
Tidsramme: Baseline to Week 8

Change from Baseline in overall skin appearance graded by a qualified dermatologist reviewing participant-submitted digital photographs using a binary Yes/No improvement scale assessing overall skin health, pigmentation, dryness, brightness, scarring, blemishes, redness, and flaking

Baseline to Week 8

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Participant-Reported Change in Skin Appearance
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin appearance assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Clarity
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin clarity assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Calmness
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin calmness assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Visible Skin Concerns
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported visible skin concerns assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Texture
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin texture assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Luminosity
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin luminosity assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Age Appearance
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin age appearance assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Itching and Irritation
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported itching and irritation assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Comfort
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin comfort assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8
Participant-Reported Change in Skin Confidence
Tidsramme: Baseline, Week 4, and Week 8

Change from Baseline in self-reported skin confidence assessed via a participant-reported skin questionnaire

Baseline, Week 4, and Week 8

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. januar 2027

Studiet fullført (Antatt)

1. januar 2027

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

12. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere